Hossein Danafar
Impact in
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery
- Molecular Medicine top 0.5%
- Curcumin's Biomedical Applications
Papers in
- Biomaterials 93
- Nanoparticle-Based Drug Delivery 90
-
- Nanoplatforms for cancer theranostics 30
- Graphene and Nanomaterials Applications 22
- Co-authors
- Hamidreza Kheiri Manjili (47 shared papers)Hamed Nosrati (58 shared papers)Ali Sharafi (46 shared papers)Soodabeh Davaran (26 shared papers)Marziyeh Salehiabar (20 shared papers)Kobra Rostamizadeh (18 shared papers)Mostafa Zamani (17 shared papers)Mehrdad Hamidi (16 shared papers)
- Journals
- Journal of Drug Delivery Science and Technology (10 papers)Applied Organometallic Chemistry (9 papers)Scientific Reports (8 papers)Pharmaceutical Development and Technology (8 papers)International Journal of Biological Macromolecules (6 papers)
- Partner nations
- IranTürkiyeUnited States
In The Last Decade
Hossein Danafar
179 papers receiving 5.5k citations
Peers
Comparison fields: 5 of 142
- Biomaterials 2.3k
- Molecular Medicine 626
- Pharmaceutical Science 559
- Biomedical Engineering 1.7k
- Organic Chemistry 691
Countries citing papers authored by Hossein Danafar
This map shows the geographic impact of Hossein Danafar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hossein Danafar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hossein Danafar more than expected).
Fields of papers citing papers by Hossein Danafar
This network shows the impact of papers produced by Hossein Danafar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hossein Danafar. The network helps show where Hossein Danafar may publish in the future.
Co-authors
The 25 scholars most cited alongside Hossein Danafar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 184 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 226 | |
| 2 | 2018 | 206 | |
| 3 | 2017 | 195 | |
| 4 | 2018 | 153 | |
| 5 | 2018 | 133 | |
| 6 | 2021 | 112 | |
| 7 | 2017 | 107 | |
| 8 | 2018 | 103 | |
| 9 | 2016 | 98 | |
| 10 | 2017 | 95 | |
| 11 | 2014 | 89 | |
| 12 | 2016 | 88 | |
| 13 | 2017 | 86 | |
| 14 | 2019 | 81 | |
| 15 | 2017 | 79 | |
| 16 | 2017 | 76 | |
| 17 | 2016 | 76 | |
| 18 | 2017 | 72 | |
| 19 | 2018 | 72 | |
| 20 | 2016 | 72 |
About Hossein Danafar
Hossein Danafar is a scholar working on Biomaterials, Biomedical Engineering, Molecular Biology, Molecular Medicine and Materials Chemistry, having authored 184 papers that have together received 5.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (90 papers), Nanoplatforms for cancer theranostics (30 papers), Curcumin's Biomedical Applications (28 papers), Graphene and Nanomaterials Applications (22 papers), Protein Interaction Studies and Fluorescence Analysis (13 papers), Advanced Polymer Synthesis and Characterization (12 papers), Flavonoids in Medical Research (12 papers) and Advanced Drug Delivery Systems (12 papers). The work is most often cited by research in Biomaterials (2.3k citations), Molecular Medicine (626 citations), Pharmaceutical Science (559 citations), Biomedical Engineering (1.7k citations) and Organic Chemistry (691 citations). Hossein Danafar has collaborated with scholars based in Iran, Türkiye and United States. Frequent co-authors include Hamidreza Kheiri Manjili, Hamed Nosrati, Ali Sharafi, Soodabeh Davaran, Marziyeh Salehiabar, Kobra Rostamizadeh, Mostafa Zamani, Mehrdad Hamidi, Mozhgan Aghajanzadeh and Elahe Attari. Their work appears in journals such as Journal of Drug Delivery Science and Technology, Applied Organometallic Chemistry, Scientific Reports, Pharmaceutical Development and Technology and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.